Trials / Terminated
TerminatedNCT02392273
A Prospective Observational Registry of Primary Headache Patients Treated With Ausanil
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- VR1 Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is an observational study with the primary objective to assess the safety and tolerability of Ausanil in the treatment of primary headache disorders. The secondary objective is to assess headache pain, functional outcome, time loss to headache and patient satisfaction with Ausanil treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ausanil | Patients with Primary Headache disorders will receive Ausanil in the context of usual and routine clinical care. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-12-01
- Completion
- 2017-01-01
- First posted
- 2015-03-18
- Last updated
- 2016-12-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02392273. Inclusion in this directory is not an endorsement.